Literatur
Moss B (2011) Smallpox vaccines: targets of protective immunity. Immunol Rev 239:8–26
Aylward RB, Acharya A, England S, Agocs M, Linkins J (2003) Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet 362:909–914
Barrett S (2004) Eradication versus control: the economics of global infectious disease policies. Bull World Health Organ 82:683–688
Wagner KS, White JM, Lucenko I et al (2012) Diphtheria Surveillance Network. Diphtheria in the postepidemic period, Europe, 2000–2009. Emerg Infect Dis 18:217–225
Goodson JL, Seward JF (2015) Measles 50 years after use of measles vaccine. Infect Dis Clin North Am 29:725–743
Aktuelle Epidemiologie von Masern in Deutschland. Epidemiologische Bulletin 2018(33):325–330
WHO (2018) Measles cases hit record high in the European Region. http://www.euro.who.int/en/media-centre/sections/press-releases/2018/measles-cases-hit-record-high-in-the-european-region
Metcalf CJ, Ferrari M, Graham AL, Grenfell BT (2015) Understanding herd immunity. Trends Immunol 36:753–755
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL (2016) Measles. Nat Rev Dis Primers 2:16049. https://doi.org/10.1038/nrdp.2016.49
Schlaud M, Poethko-Müller C, Kuhnert R, Hecker H (Erscheinungsdatum 24. Januar 2014 beim RKI) Endbericht der TOKEN-Studie. Studie über Todesfälle bei Kindern im 2. bis 24. Lebensmonat. https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/Weitere_Studien/TOKEN_Studie/Studyreport.html
Mentzer D, Oberle D, Keller-Stanislawski B (2018) Daten zur Pharmakovigilanz von Impfstoffen aus dem Jahr 2016. Bull Arzneimittelsicherheit 1:17–24
Offit PA, Quarles J, Gerber MA, Hackett CJ, Marcuse EK, Kollman TR, Gellin BG, Landry S (2002) Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics 109(1):124–129
Perricone C, Agmon-Levin N, Shoenfeld Y (2013) Novel pebbles in the mosaic of autoimmunity. Bmc Med 11:101
van der Laan JW, Gould S, Tanir JY, ILSI HESI Vaccines and Adjuvants Safety Project Committee (2015) Safety of vaccine adjuvants: focus on autoimmunity. Vaccine 33:1507–1514
Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’—autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4–8
Hawkes D, Benhamu J, Sidwell T, Miles R, Dunlop RA (2015) Revisiting adverse reactions to vaccines: a critical appraisal of autoimmune syndrome induced by adjuvants (ASIA). J Autoimmun 59:77–84
Pellegrino P, Perrone V, Pozzi M et al (2015) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res 61:90–96
Wakefield AJ, Murch SH, Anthony A et al (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637–641
Murch SH, Anthony A, Casson DH et al (2004) Retraction of an interpretation. Lancet 363:750
The Lancet (2010) Retraction—ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445
Parker SK, Schwartz B, Todd J, Pickering LK (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114:793–804
Taylor LE, Swerdfeger AL, Eslick GD (2014) Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine 32:3623–3629
Keller-Stanislawski B et al (2014) Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32(52):7057–7064
Volz-Zang C (2014) Sicherheit von Impfungen während der Schwangerschaft. Bull Zur Arzneimittelsicherheit 4:16–20
Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME (2015) Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis. Obstet Gynecol 126:1075–1084
Makris MC, Polyzos KA, Mavros MN, Athanasiou S, Rafailidis PI, Falagas ME (2012) Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf 35:1–14
Castillo-Solorzano C, Reef SE, Morice A et al (2011) Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001–2008. J Infect Dis 204(Suppl 2):S713–717
Wilson E, Goss MA, Marin M et al (2008) Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. J Infect Dis 197(Suppl 2):S178–S184
Suryadevara M, Domachowske JB (2015) Prevention of pertussis through adult vaccination. Hum Vaccin Immunother 11:1744–1747
Centers for Disease Control and Prevention (2011) CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged 〈12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60:1424–1426
Boylston A (2013) The origins of vaccination: myths and reality. J R Soc Med 106(9):351–354
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
F. Zepp ist seit 1998 Mitglied der Ständigen Impfkommission beim RKI.
Dieser Beitrag beinhaltet keine von dem Autor durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
G. Hansen, Hannover
R. Kerbl, Leoben
F. Zepp, Mainz
Rights and permissions
About this article
Cite this article
Zepp, F. Impfmythen in der Pädiatrie. Monatsschr Kinderheilkd 166, 1114–1119 (2018). https://doi.org/10.1007/s00112-018-0610-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-018-0610-3